Listar por autoría "5f156ef4-2a70-48fc-b3ca-f9bd306cc167"

Mostrando ítems 1-8 de 8

    • openAccess   Comparison of Peritoneal Carcinomatosis Scoring Methods in Predicting Resectability and Prognosis in Gynecologic Malignancies 

      CLIMENT MARTÍ, MARIA TERESA; Serra Rubert, Anna; Gilabert-Estellés, Juan; Gilabert-Aguilar, Juan; Llueca, Antoni MDPI (2021-06-09)
      Objective: Peritoneal carcinomatosis is a disease’s presentation in the advanced stages of many gynecologic tumours. The distribution and volume of the disease are the main factors in achieving complete debulking. ...

    • closedAccess   Diferencias entre distintos niveles de dedicación a la danza para variables de estrés y afrontamiento 

      CLIMENT MARTÍ, MARIA TERESA Universitat Jaume I (2020-07-15)
      La relación entre el deporte y el estrés ha supuesto un gran interés de estudio, no siendo así cuando se trata del ámbito de la danza. La danza es una actividad cultural humana que reúne las características de la actividad ...

    • openAccess   Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Associated with Cytoreductive Surgery in the Treatment of Advanced Ovarian Cancer: Systematic Review and Meta-Analysis 

      Llueca, Maria; Ibáñez Gual, Maria Victoria; CLIMENT MARTÍ, MARIA TERESA; Serra Rubert, Anna; Llueca, Antoni MDPI (2023-01-30)
      Objective: The use of hyperthermic intraperitoneal chemotherapy (HIPEC) as a treatment for epithelial ovarian cancer remains controversial. Our study aims to analyze the overall survival and disease-free survival for the ...

    • openAccess   Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study 

      Llueca, Antoni; Ibáñez Gual, Maria Victoria; CASCALES SANCHEZ, PEDRO; Gil-Moreno, Antonio; Bebia, Vicente; Ponce, Jordi; Fernandez, Sergi; Arjona-Sanchez, Alvaro; Muruzabal Torquemada, Juan Carlos; Veiga-Canuto, Nadia; Díaz-Feijoo, Berta; Celada Castro, Cristina; Gilabert-Estellés, Juan; AGHABABYAN, KRISTINA; Lacueva, Francisco Javier; Calero, Alicia; Segura-Sampedro, Juan José; Maiocchi, Karina; Llorca Cardeñosa, Sara; Villarín, Álvaro; CLIMENT MARTÍ, MARIA TERESA; Delgado Barriga, Katty; Serra Rubert, Anna; GOMEZ QUILES, LUIS; Llueca, Maria; Spain GOG and GECOP Working Group MDPI (2023-08-26)
      Simple Summary Advanced ovarian cancer (Stages III-IV) continues to be one of the gynecological tumors with the highest mortality. Standard treatment consists of debulking surgery and subsequent adjuvant chemotherapy. ...

    • openAccess   Outcome quality standards in advanced ovarian cancer surgery 

      Llueca, Antoni; Serra Rubert, Anna; CLIMENT MARTÍ, MARIA TERESA; Segarra vidal , Blanca; Maazouzi, Yasmine; Soriano, Marta; Escrig-Sos, Javier (2020-12-07)
      Advanced ovarian cancer surgery (AOCS) frequently results in serious postoperative complications. Because managing AOCS is difficult, some standards need to be established that allow surgeons to assess the quality of ...

    • openAccess   Postoperative intestinal fistula in primary advanced ovarian cancer surgery 

      Llueca, Antoni; Serra Rubert, Anna; CLIMENT MARTÍ, MARIA TERESA; Maiocchi, Karina; Villarín, Álvaro; Delgado Barriga, Katty; Marí-Alexandre, Josep; Gilabert-Estellés, Juan; Carrasco, Paula; Segarra vidal , Blanca; GOMEZ QUILES, LUIS; Hidalgo Mora, Juan José; Escrig-Sos, Javier; Laguna Sastre, José Manuel Dove Medical Press (2021-01-06)
      Background: Advanced ovarian cancer (AOC) requires an aggressive surgery with large visceral resections in order to achieve an optimal or complete cytoreduction and increase the patient’s survival. However, the surgical ...

    • openAccess   Surgery in Recurrent Ovarian Cancer: A Meta-Analysis 

      CLIMENT MARTÍ, MARIA TERESA; Serra Rubert, Anna; Llueca, Maria; Llueca, Antoni MDPI (2023-07-02)
      Simple Summary Ovarian cancer has the highest mortality rate of any type of gynecological cancer because it is diagnosed in advanced stages and its recurrence rate is about 80%. The standard treatment for recurrences of ...

    • openAccess   Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer 

      Llueca, Antoni; CLIMENT MARTÍ, MARIA TERESA; Escrig-Sos, Javier; Carrasco, Paula; Serra Rubert, Anna; Gómez-Quiles, Luis; Játiva, R.; Cebrian, G.; Boso Ribelles, Virginia; Villarin, A.; Maiocchi, Karina; Delgado Barriga, Katty; RODRIGO-ALIAGA, MIGUEL; Ruiz, N.; Herrero, C.; Frances, A.; Beato, I.; Ferrer, C.; Kessler, Juan Pablo Aracil; Boldo Roda, Enrique; Boldo, A.; Adell, R. Nature Research (2021-04-14)
      The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these patients. The ability to perform complete ...